• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down0.26% Nasdaq Down0.34%

    NuVasive, Inc. (NUVA)

    -NasdaqGS
    47.49 Up 0.20(0.42%) Jul 6, 4:00PM EDT
    |After Hours : 47.49 0.00 (0.00%) Jul 6, 5:30PM EDT
    Add to Portfolio
    ProfileGet Profile for:
    NuVasive, Inc.
    7475 Lusk Boulevard
    San Diego, CA 92121
    United States - Map
    Phone: 858-909-1800
    Fax: 800-475-9134
    Website: http://www.nuvasive.com

    Details 
    Index Membership:N/A
    Sector:Healthcare
    Industry:Medical Appliances & Equipment
    Full Time Employees:1,500

    Business Summary 

    NuVasive, Inc., a medical device company, develops and markets minimally-disruptive surgical products and procedurally-integrated solutions for the spine. Its products focus on applications for spine fusion surgery. The company’s principal product is Maximum Access Surgery (MAS), a minimally-disruptive surgical platform that includes its proprietary software-driven nerve detection and avoidance systems, NVM5 and NVJJB, and intra-operative monitoring (IOM) services and support; MaXcess, an integrated split-blade retractor system; and various specialized implants and biologics. Its spine surgery product line offerings comprise products for the thoracolumbar and the cervical spine, which are primarily used to enable surgeons access to the spine and to perform restorative and fusion procedures in a minimally disruptive fashion. The company’s biologic product line offerings used to aid the spinal fusion process or bone healing process consist of Osteocel Plus and Osteocel Pro allograft (donated human tissue), which are cellular matrix products containing viable mesenchymal stem cells; FormaGraft, a collagen synthetic product; and AttraX, a synthetic bone graft material. It also provides IOM services for insight into the nervous system during non-spine. The company sells its products through independent sales agencies, directly-employed sales shareowners to surgeons and hospitals in the United States and internationally. NuVasive, Inc. was founded in 1997 and is headquartered in San Diego, California.

    Key Statistics


    Company Websites 
    Home Page
    Search Yahoo! for:
    More on NuVasive, Inc.

    Corporate Governance 
    NuVasive, Inc.’s ISS Governance QuickScore as of Jun 1, 2015 is 4. The pillar scores are Audit: 2; Board: 3; Shareholder Rights: 5; Compensation: 5.
    Brought to you by Institutional Shareholder Services (ISS)

    Key Executives 
     PayExercised
    Mr. Gregory T. Lucier , 51
    Chairman and Chief Exec. Officer
    72.00KN/A
    Mr. Patrick Miles , 49
    Pres and Chief Operating Officer
    1.14M2.07M
    Mr. Quentin Blackford , 36
    Chief Financial Officer, Chief Accounting Officer and Exec. VP
    731.00K249.00K
    Mr. Jason M. Hannon , 43
    Exec. VP of Corp. Devel., Gen. Counsel and Sec.
    839.00K1.30M
    Mr. Alexis V. Lukianov , 59
    Consultant
    1.99M880.00K
    Amounts are as of Dec 31, 2014 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in USD.
    View Insiders